El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 

Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing

dc.contributor.authorSan José, Antonio
dc.contributor.authorAgustí, Antonia
dc.contributor.authorVidal, Xavier
dc.contributor.authorFormiga Pérez, Francesc
dc.contributor.authorLópez-Soto, Alfonso
dc.contributor.authorFernández Moyano, Antonio
dc.contributor.authorGarcía, Juana
dc.contributor.authorRamírez Duque, Nieves
dc.contributor.authorTorres, Olga H.
dc.contributor.authorBarbé, José
dc.date.accessioned2015-12-17T17:06:49Z
dc.date.available2015-12-17T17:06:49Z
dc.date.issued2014-08-29
dc.date.updated2015-12-17T17:06:49Z
dc.description.abstractPurpose: This study aims to assess inappropriate prescribing (IP) to elderly patients during the month prior to hospitalization and to compare different IP criteria. Methods: An observational, prospective and multicentric study was carried out in the internal medicine services of seven Spanish hospitals. Patients aged 75 years and older were randomly selected after hospital admission for a year. To assess potentially inappropriate medicines (PIMs), the Beers and STOPP criteria were used and to assess Potentially Prescribing Omissions (PPOs), the START criteria and ACOVE-3 medicine quality indicators were used. An analysis to assess factors associated with IP was performed. Results: 672 patients [median age (Q1_Q3) 82 (79-86) years, 55.9% female] were included. Median prescribed medicines in the month prior to hospitalization were 10(Q1-Q3 7-13). The prevalence of IP was 87.6%, and 54.3% of patients had PIMs and PPOs concurrently. A higher prevalence rate of PIMs was predicted using the STOPP criteria than with the Beers criteria (p<.001) and a higher prevalence of PPOs using the ACOVE-3 criteria than using the START criteria (p<.001) was observed. Polypharmacy (≥10 medicines) was the strongest predictor of IP [OR=11.34 95% confidence interval (CI) 4.96-25.94], PIMs [OR=14.16, 95% CI 6.44-31.12], Beers-listed PIMs [OR=8.19, 95% CI 3.01-22.28] and STOPP-listed PIMs [OR=8.21, 95% CI 3.47-19.44]. PIMs was the strongest predictor of PPOs [OR=2.79, 95% CI 1.81-4.28]. Conclusions: A high prevalence of polypharmacy and PIMs and PPOs were reported. More than half the patients had simultaneous PIMs and PPOs. The related factors to PIMs and PPOs were different.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec648242
dc.identifier.issn0953-6205
dc.identifier.urihttps://hdl.handle.net/2445/68493
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1016/j.ejim.2014.07.011
dc.relation.ispartofEuropean Journal Of Internal Medicine, 2014, vol. 25, num. 8, p. 710-716
dc.relation.urihttp://dx.doi.org/10.1016/j.ejim.2014.07.011
dc.rights(c) Elsevier B.V., 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationPrescripció de medicaments
dc.subject.classificationMalalties de les persones grans
dc.subject.classificationAdministració de medicaments
dc.subject.otherDrug prescribing
dc.subject.otherOlder people diseases
dc.subject.otherAdministration of drugs
dc.titleInappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
648242.pdf
Mida:
124.28 KB
Format:
Adobe Portable Document Format